Grant E. Boldt

693 total citations
18 papers, 555 citations indexed

About

Grant E. Boldt is a scholar working on Molecular Biology, Neurology and Organic Chemistry. According to data from OpenAlex, Grant E. Boldt has authored 18 papers receiving a total of 555 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Neurology and 3 papers in Organic Chemistry. Recurrent topics in Grant E. Boldt's work include Botulinum Toxin and Related Neurological Disorders (5 papers), Alzheimer's disease research and treatments (3 papers) and Neurological disorders and treatments (3 papers). Grant E. Boldt is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (5 papers), Alzheimer's disease research and treatments (3 papers) and Neurological disorders and treatments (3 papers). Grant E. Boldt collaborates with scholars based in United States, United Kingdom and Mexico. Grant E. Boldt's co-authors include Kim D. Janda, Jack P. Kennedy, Mark S. Hixon, Saul Tzipori, Tobin J. Dickerson, N.R. Silvaggi, Joseph Barbieri, Karen N. Allen, Lisa M. Eubanks and Paul Wentworth and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and Biochemistry.

In The Last Decade

Grant E. Boldt

18 papers receiving 543 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Grant E. Boldt United States 13 309 253 118 73 65 18 555
Jørn Døvling Kaspersen Denmark 12 237 0.8× 297 1.2× 43 0.4× 23 0.3× 47 0.7× 15 727
Suzana Aulić Italy 14 98 0.3× 351 1.4× 38 0.3× 47 0.6× 48 0.7× 24 618
Carla M. Koehler United States 12 69 0.2× 482 1.9× 49 0.4× 23 0.3× 22 0.3× 13 627
Benedikt Frieg Germany 14 93 0.3× 286 1.1× 44 0.4× 17 0.2× 27 0.4× 25 488
Salvador Guardiola Spain 10 115 0.4× 256 1.0× 50 0.4× 94 1.3× 60 0.9× 19 519
Fernando J. Irazoqui Argentina 14 92 0.3× 363 1.4× 60 0.5× 17 0.2× 107 1.6× 36 557
Abida Arshad Pakistan 8 32 0.1× 200 0.8× 28 0.2× 58 0.8× 35 0.5× 25 434
Peter Šilhár United States 14 160 0.5× 187 0.7× 59 0.5× 46 0.6× 165 2.5× 27 461
Alan Akiyama United States 8 29 0.1× 273 1.1× 84 0.7× 29 0.4× 66 1.0× 13 531

Countries citing papers authored by Grant E. Boldt

Since Specialization
Citations

This map shows the geographic impact of Grant E. Boldt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grant E. Boldt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grant E. Boldt more than expected).

Fields of papers citing papers by Grant E. Boldt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grant E. Boldt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grant E. Boldt. The network helps show where Grant E. Boldt may publish in the future.

Co-authorship network of co-authors of Grant E. Boldt

This figure shows the co-authorship network connecting the top 25 collaborators of Grant E. Boldt. A scholar is included among the top collaborators of Grant E. Boldt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grant E. Boldt. Grant E. Boldt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Nieva, Jorge J., et al.. (2011). Cholesterol Secosterol Aldehydes Induce Amyloidogenesis and Dysfunction of Wild-Type Tumor Protein p53. Chemistry & Biology. 18(7). 920–927. 34 indexed citations
2.
Scheinost, Johanna C., et al.. (2009). Cholesterol Secosterol Adduction Inhibits the Misfolding of a Mutant Prion Protein Fragment that Induces Neurodegeneration. Angewandte Chemie International Edition. 48(50). 9469–9472. 11 indexed citations
3.
Chen, Yanping, et al.. (2009). The Natural Products Beauveriolide I and III: a New Class of β‐Amyloid‐Lowering Compounds. ChemBioChem. 10(8). 1344–1347. 16 indexed citations
4.
Cole, Michael, Sarah E. Tully, Alister W. Dodds, et al.. (2009). A Chemical Approach to Immunoprotein Engineering: Chemoselective Functionalization of Thioester Proteins in Their Native State. ChemBioChem. 10(8). 1340–1343. 6 indexed citations
5.
Scheinost, Johanna C., Hong Wang, Grant E. Boldt, John Offer, & Paul Wentworth. (2008). Cholesterol seco‐Sterol‐Induced Aggregation of Methylated Amyloid‐β Peptides—Insights into Aldehyde‐Initiated Fibrillization of Amyloid‐β. Angewandte Chemie International Edition. 47(21). 3919–3922. 17 indexed citations
6.
Scheinost, Johanna C., Hong Wang, Grant E. Boldt, John Offer, & Paul Wentworth. (2008). Cholesterol seco‐Sterol‐Induced Aggregation of Methylated Amyloid‐β Peptides—Insights into Aldehyde‐Initiated Fibrillization of Amyloid‐β. Angewandte Chemie. 120(21). 3983–3986. 2 indexed citations
7.
Silvaggi, N.R., Grant E. Boldt, Mark S. Hixon, et al.. (2007). Structures of Clostridium botulinum Neurotoxin Serotype A Light Chain Complexed with Small-Molecule Inhibitors Highlight Active-Site Flexibility. Chemistry & Biology. 14(5). 533–542. 102 indexed citations
8.
Boldt, Grant E., Lisa M. Eubanks, & Kim D. Janda. (2006). Identification of a botulinum neurotoxin A protease inhibitor displaying efficacy in a cellular model. Chemical Communications. 3063–3063. 42 indexed citations
9.
Xu, Yang, Hong Lü, Jack P. Kennedy, et al.. (2006). Evaluation of “Credit Card” Libraries for Inhibition of HIV-1 gp41 Fusogenic Core Formation. Journal of Combinatorial Chemistry. 8(4). 531–539. 21 indexed citations
10.
Boldt, Grant E., Tobin J. Dickerson, & Kim D. Janda. (2006). Emerging chemical and biological approaches for the preparation of discovery libraries. Drug Discovery Today. 11(3-4). 143–148. 17 indexed citations
11.
Boldt, Grant E., Jack P. Kennedy, Mark S. Hixon, et al.. (2006). Synthesis, Characterization and Development of a High-Throughput Methodology for the Discovery of Botulinum Neurotoxin A Inhibitors. Journal of Combinatorial Chemistry. 8(4). 513–521. 63 indexed citations
12.
Fu, Zhuji, Sheng Chen, Michael R. Baldwin, et al.. (2006). Light Chain of Botulinum Neurotoxin Serotype A:  Structural Resolution of a Catalytic Intermediate,. Biochemistry. 45(29). 8903–8911. 46 indexed citations
13.
Boldt, Grant E., Jack P. Kennedy, & Kim D. Janda. (2006). Identification of a Potent Botulinum Neurotoxin A Protease Inhibitor Using in Situ Lead Identification Chemistry. Organic Letters. 8(8). 1729–1732. 94 indexed citations
14.
McKenzie, Kathleen M., Michaël M. Meijler, Colin A. Lowery, Grant E. Boldt, & Kim D. Janda. (2005). A furanosyl-carbonate autoinducer in cell-to-cell communication of V. harveyi. Chemical Communications. 4863–4863. 11 indexed citations
15.
Zhang, Ligang, Hai Long, Grant E. Boldt, et al.. (2005). α- and β-Stilbenosides as base-pair surrogates in DNA hairpins. Organic & Biomolecular Chemistry. 4(2). 314–322. 10 indexed citations
16.
Reed, Neal N., Tobin J. Dickerson, Grant E. Boldt, & Kim D. Janda. (2005). Enantioreversal in the Sharpless Asymmetric Epoxidation Reaction Controlled by the Molecular Weight of a Covalently Appended Achiral Polymer. The Journal of Organic Chemistry. 70(5). 1728–1731. 24 indexed citations
17.
Brogan, Andrew P., Tobin J. Dickerson, Grant E. Boldt, & Kim D. Janda. (2005). Altered retinoid homeostasis catalyzed by a nicotine metabolite: Implications in macular degeneration and normal development. Proceedings of the National Academy of Sciences. 102(30). 10433–10438. 26 indexed citations
18.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jørn Døvling Kaspersen Breakdown of academic impact, for papers by Suzana Aulić Breakdown of academic impact, for papers by Carla M. Koehler Breakdown of academic impact, for papers by Benedikt Frieg Breakdown of academic impact, for papers by Salvador Guardiola Breakdown of academic impact, for papers by Fernando J. Irazoqui Breakdown of academic impact, for papers by Abida Arshad Breakdown of academic impact, for papers by Peter Šilhár Breakdown of academic impact, for papers by Alan Akiyama
Rankless by CCL
2026